CONCORDBIO — Concord Biotech Share News
0.000.00%
Last trade - 00:00- IN₹128.60bn
- IN₹124.18bn
- IN₹10.55bn
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval
Brief: Concord Biotech Gets Abbreviated New Drug Application Approval For Tofacitinib Tablets, 5 Mg And 10 Mg
India's Concord Biotech rises on US FDA approval for Mycophenolate Mofetil
Brief: Concord Biotech Ltd Received Approval From USFDA For Mycophenolate Mofetil For Oral Suspension USP, 200 Mg/Ml
India's Concord Biotech falls; Citi cuts TP on slower revenue growth outlook
Brief: Concord Biotech Dec-Quarter Consol Net Profit 644.8 Million Rupees
Brief: Concord Biotech Appoints Raviraj Karia As CFO
Brief: Concord Biotech Says CFO Lalit Sethi To Retire
Brief: Concord Biotech posts Sept-Quarter Consol Net Profit 635.8 Million Rupees
Brief: Concord Biotech - Approves Acquisition Of 100% Equity In Celliimune Biotech
Brief: Concord Biotech Says EU-GMP Conducts First Inspection Of API Facility
Brief: Concord Biotech To Expand Operations In USA
Brief: Concord Biotech Updates On USFDA Inspection At API Facility At Dholka
India's Concord Biotech climbs on higher quarterly profit
Brief: Concord Biotech Says Granted Approval From USFDA For Marketing Its Teriflunomide Tablets
Brief: Concord Biotech Commences Production At New Valthera Facility